TickerFactsScreenerDevelopers

HALOZYME THERAPEUTICS, INC. (HALO) — Total Assets

Annual figures by fiscal year, from SEC filings.

2010: $91.35M2011: $65.76M2012: $134.73M2013: $101.79M2014: $165.98M2015: $181.79M2016: $261.51M2017: $519.95M2018: $440.25M2019: $565.87M2020: $579.92M2021: $1.10B2022: $1.84B2023: $1.73B2024: $2.06B2025: $2.53B$2.53B
2010Total Assets (USD)2025
Fiscal YearTotal AssetsChange YoY
2025$2.53B+22.4%
2024$2.06B+19.1%
2023$1.73B-5.9%
2022$1.84B+66.7%
2021$1.10B+90.4%
2020$579.92M+2.5%
2019$565.87M+28.5%
2018$440.25M-15.3%
2017$519.95M+98.8%
2016$261.51M+43.9%
2015$181.79M+9.5%
2014$165.98M+63.1%
2013$101.79M-24.4%
2012$134.73M+104.9%
2011$65.76M-28.0%
2010$91.35M—